Self-association of human PCSK9 correlates with its LDLR-degrading activity

Daping Fan, Patricia G. Yancey, Shenfeng Qiu, Lei Ding, Edwin J. Weeber, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Genetic studies have demonstrated an important role for proprotein convertase subtilisin/kexin type 9 (PCSK9) as a determinant of plasma cholesterol levels. However, the underlying molecular mechanism is not completely understood. To this end, we have generated a mammalian cell expression system for human PCSK9 and its mutants and produced transgenic mice expressing human PCSK9. HEK293T cells transfected with the human PCSK9 DNA construct expressed and secreted PCSK9 and displayed decreased LDLR levels; functional PCSK9 protein was purified from the conditioned medium. In vitro studies showed that PCSK9 self-associated in a concentration-, temperature-, and pH-dependent manner. A mixture of PCSK9 monomers, dimers, and trimers displayed an enhanced LDLR degrading activity compared to monomeric PCSK9. A gain-of-function mutant, D374Y, displayed greatly increased self-association compared to wild-type PCSK9. Moreover, we demonstrated that the catalytic domain of PCSK9 is responsible for the self-association. Self-association of PCSK9 was enhanced by incubation with mouse apoE-/- VLDL and inhibited by incubation with both human and mouse HDL. When PCSK9 protein was incubated with total serum, it partially associated with LDL and HDL but not with VLDL. In transgenic mice, PCSK9 also associated with LDL and HDL but not with VLDL. We conclude that self-association is an intrinsic property of PCSK9, correlated to its LDLR-degrading activity and affected by plasma lipoproteins. These results provide a basis for developing strategies to manipulate PCSK9 activity in the circulation for the treatment of hypercholesterolemia.

Original languageEnglish (US)
Pages (from-to)1631-1639
Number of pages9
JournalBiochemistry
Volume47
Issue number6
DOIs
StatePublished - Feb 12 2008
Externally publishedYes

Fingerprint

Proprotein Convertases
Subtilisin
human PCSK9 protein
Proprotein Convertase 9
Transgenic Mice
Plasmas
Apolipoproteins E
Conditioned Culture Medium
Dimers
Hypercholesterolemia
Lipoproteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Fan, D., Yancey, P. G., Qiu, S., Ding, L., Weeber, E. J., Linton, M. F., & Fazio, S. (2008). Self-association of human PCSK9 correlates with its LDLR-degrading activity. Biochemistry, 47(6), 1631-1639. https://doi.org/10.1021/bi7016359

Self-association of human PCSK9 correlates with its LDLR-degrading activity. / Fan, Daping; Yancey, Patricia G.; Qiu, Shenfeng; Ding, Lei; Weeber, Edwin J.; Linton, MacRae F.; Fazio, Sergio.

In: Biochemistry, Vol. 47, No. 6, 12.02.2008, p. 1631-1639.

Research output: Contribution to journalArticle

Fan, D, Yancey, PG, Qiu, S, Ding, L, Weeber, EJ, Linton, MF & Fazio, S 2008, 'Self-association of human PCSK9 correlates with its LDLR-degrading activity', Biochemistry, vol. 47, no. 6, pp. 1631-1639. https://doi.org/10.1021/bi7016359
Fan D, Yancey PG, Qiu S, Ding L, Weeber EJ, Linton MF et al. Self-association of human PCSK9 correlates with its LDLR-degrading activity. Biochemistry. 2008 Feb 12;47(6):1631-1639. https://doi.org/10.1021/bi7016359
Fan, Daping ; Yancey, Patricia G. ; Qiu, Shenfeng ; Ding, Lei ; Weeber, Edwin J. ; Linton, MacRae F. ; Fazio, Sergio. / Self-association of human PCSK9 correlates with its LDLR-degrading activity. In: Biochemistry. 2008 ; Vol. 47, No. 6. pp. 1631-1639.
@article{029ba5811dc746c08f05dd384231750b,
title = "Self-association of human PCSK9 correlates with its LDLR-degrading activity",
abstract = "Genetic studies have demonstrated an important role for proprotein convertase subtilisin/kexin type 9 (PCSK9) as a determinant of plasma cholesterol levels. However, the underlying molecular mechanism is not completely understood. To this end, we have generated a mammalian cell expression system for human PCSK9 and its mutants and produced transgenic mice expressing human PCSK9. HEK293T cells transfected with the human PCSK9 DNA construct expressed and secreted PCSK9 and displayed decreased LDLR levels; functional PCSK9 protein was purified from the conditioned medium. In vitro studies showed that PCSK9 self-associated in a concentration-, temperature-, and pH-dependent manner. A mixture of PCSK9 monomers, dimers, and trimers displayed an enhanced LDLR degrading activity compared to monomeric PCSK9. A gain-of-function mutant, D374Y, displayed greatly increased self-association compared to wild-type PCSK9. Moreover, we demonstrated that the catalytic domain of PCSK9 is responsible for the self-association. Self-association of PCSK9 was enhanced by incubation with mouse apoE-/- VLDL and inhibited by incubation with both human and mouse HDL. When PCSK9 protein was incubated with total serum, it partially associated with LDL and HDL but not with VLDL. In transgenic mice, PCSK9 also associated with LDL and HDL but not with VLDL. We conclude that self-association is an intrinsic property of PCSK9, correlated to its LDLR-degrading activity and affected by plasma lipoproteins. These results provide a basis for developing strategies to manipulate PCSK9 activity in the circulation for the treatment of hypercholesterolemia.",
author = "Daping Fan and Yancey, {Patricia G.} and Shenfeng Qiu and Lei Ding and Weeber, {Edwin J.} and Linton, {MacRae F.} and Sergio Fazio",
year = "2008",
month = "2",
day = "12",
doi = "10.1021/bi7016359",
language = "English (US)",
volume = "47",
pages = "1631--1639",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Self-association of human PCSK9 correlates with its LDLR-degrading activity

AU - Fan, Daping

AU - Yancey, Patricia G.

AU - Qiu, Shenfeng

AU - Ding, Lei

AU - Weeber, Edwin J.

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2008/2/12

Y1 - 2008/2/12

N2 - Genetic studies have demonstrated an important role for proprotein convertase subtilisin/kexin type 9 (PCSK9) as a determinant of plasma cholesterol levels. However, the underlying molecular mechanism is not completely understood. To this end, we have generated a mammalian cell expression system for human PCSK9 and its mutants and produced transgenic mice expressing human PCSK9. HEK293T cells transfected with the human PCSK9 DNA construct expressed and secreted PCSK9 and displayed decreased LDLR levels; functional PCSK9 protein was purified from the conditioned medium. In vitro studies showed that PCSK9 self-associated in a concentration-, temperature-, and pH-dependent manner. A mixture of PCSK9 monomers, dimers, and trimers displayed an enhanced LDLR degrading activity compared to monomeric PCSK9. A gain-of-function mutant, D374Y, displayed greatly increased self-association compared to wild-type PCSK9. Moreover, we demonstrated that the catalytic domain of PCSK9 is responsible for the self-association. Self-association of PCSK9 was enhanced by incubation with mouse apoE-/- VLDL and inhibited by incubation with both human and mouse HDL. When PCSK9 protein was incubated with total serum, it partially associated with LDL and HDL but not with VLDL. In transgenic mice, PCSK9 also associated with LDL and HDL but not with VLDL. We conclude that self-association is an intrinsic property of PCSK9, correlated to its LDLR-degrading activity and affected by plasma lipoproteins. These results provide a basis for developing strategies to manipulate PCSK9 activity in the circulation for the treatment of hypercholesterolemia.

AB - Genetic studies have demonstrated an important role for proprotein convertase subtilisin/kexin type 9 (PCSK9) as a determinant of plasma cholesterol levels. However, the underlying molecular mechanism is not completely understood. To this end, we have generated a mammalian cell expression system for human PCSK9 and its mutants and produced transgenic mice expressing human PCSK9. HEK293T cells transfected with the human PCSK9 DNA construct expressed and secreted PCSK9 and displayed decreased LDLR levels; functional PCSK9 protein was purified from the conditioned medium. In vitro studies showed that PCSK9 self-associated in a concentration-, temperature-, and pH-dependent manner. A mixture of PCSK9 monomers, dimers, and trimers displayed an enhanced LDLR degrading activity compared to monomeric PCSK9. A gain-of-function mutant, D374Y, displayed greatly increased self-association compared to wild-type PCSK9. Moreover, we demonstrated that the catalytic domain of PCSK9 is responsible for the self-association. Self-association of PCSK9 was enhanced by incubation with mouse apoE-/- VLDL and inhibited by incubation with both human and mouse HDL. When PCSK9 protein was incubated with total serum, it partially associated with LDL and HDL but not with VLDL. In transgenic mice, PCSK9 also associated with LDL and HDL but not with VLDL. We conclude that self-association is an intrinsic property of PCSK9, correlated to its LDLR-degrading activity and affected by plasma lipoproteins. These results provide a basis for developing strategies to manipulate PCSK9 activity in the circulation for the treatment of hypercholesterolemia.

UR - http://www.scopus.com/inward/record.url?scp=38949103409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949103409&partnerID=8YFLogxK

U2 - 10.1021/bi7016359

DO - 10.1021/bi7016359

M3 - Article

C2 - 18197702

AN - SCOPUS:38949103409

VL - 47

SP - 1631

EP - 1639

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 6

ER -